 | Up a level |
Bohlius, Julia; Bohlius, J; Schmidlin, K; Costagliola, D; Fätkenheuer, G; May, M; Caro-Murillo, AM; Mocroft, A; Bonnet, F; Clifford, G; Karafoulidou, A; Miro, JM; Lundgren, J; Chene, G; Egger, Matthias (2009). Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study. Antiviral therapy, 14(8), pp. 1065-74. London: International Medical Press 10.3851/IMP1462
May, M; Sterne, JA; Sabin, C; Costagliola, D; Justice, AC; Thiébaut, R; Gill, J; Phillips, A; Reiss, P; Hogg, R; Ledergerber, B; D'Arminio Monforte, A; Schmeisser, N; Staszewski, S; Antiretroviral, Therapy (ART) Cohort Collaboration (2007). Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies. AIDS, 21(9), pp. 1185-1197. Hagerstown, Md.: Lippincott Williams & Wilkins
May, MT; Sterne, JA; Costagliola, D; Sabin, CA; Phillips, AN; Justice, AC; Dabis, F; Gill, J; Lundgren, J; Hogg, RS; de Wolf, F; Fätkenheuer, G; Staszewski, S; d'Arminio Monforte, A; Egger, Matthias; The Antiretroviral Therapy (ART) Cohort Collaboration, (2006). HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis. Lancet, 368(9534), pp. 451-458. London: Elsevier 10.1016/S0140-6736(06)69152-6
